Leydig Cell Tumor: Clinical Trials

1 trial for Leydig Cell Tumor, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed. 1 Not applicable.

By phase and status

PhaseTrialsStatus
Not applicable1Completed 1

Follow Leydig Cell Tumor: new trials by email Literature Review of Leydig Cell Tumor trials Research Report on Leydig Cell Tumor

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Stress Reduction in Improving Quality of Life in Patients With Recurrent Gynecologic or Breast Cancer
questionnaire administration, quality-of-life assessment, psychosocial assessment and care - Anxiety Disorder, Depression
Not applicableCompletedOhio State University Comprehensive Cancer Center392010-10-012015-10-09

Narrower conditions

Anxiety Disorders (1)  ·  Breast Neoplasms (1)  ·  Carcinoma, Ovarian Epithelial (1)  ·  Depression (1)  ·  Endometrial Neoplasms (1)  ·  Fallopian Tube Neoplasms (1)  ·  Fatigue (1)  ·  Gestational Trophoblastic Disease (1)  ·  Pain (1)  ·  Peritoneal Neoplasms (1)  ·  Pseudomyxoma Peritonei (1)  ·  Uterine Cervical Neoplasms (1)  ·  Vaginal Neoplasms (1)  ·  Vulvar Neoplasms (1)

Broader conditions

Abdominal Neoplasms (1)  ·  Adenocarcinoma (1)  ·  Adenocarcinoma, Mucinous (1)  ·  Adnexal Diseases (1)  ·  Behavior (1)  ·  Behavioral Symptoms (1)  ·  Breast Diseases (1)  ·  Carcinoma (1)  ·  Digestive System Diseases (1)  ·  Digestive System Neoplasms (1)  ·  Endocrine Gland Neoplasms (1)  ·  Endocrine System Diseases (1)  ·  Fallopian Tube Diseases (1)  ·  Female Urogenital Diseases (1)  ·  Female Urogenital Diseases and Pregnancy Complications (1)

Interventions

Behavior Therapy (1)  ·  Early Intervention, Educational (1)  ·  Methods (1)  ·  Psychiatric Rehabilitation (1)

Sponsors

Ohio State University Comprehensive Cancer Center (1)

Countries

United States (1)

Top investigators

Barbara Andersen, PhD (1)

NIH funding

R21CA135005 (1)